Key Takeaways
- •Adaptive immunity depends on the specific recognition of an antigenic peptide bound to a major histocompatibility complex (pMHC) molecule by a T cell receptor (TCR) on the surface of T cells.
- •These transmembrane glycoproteins define distinct T cell subsets.
- •CD4 and CD8 enhance T cell signaling by binding specifically to MHC class II and MHC class I molecules, respectively, on antigen-presenting cells (APCs).
T Cell Recognition and Co-Receptor Function
Adaptive immunity depends on the specific recognition of an antigenic peptide bound to a major histocompatibility complex (pMHC) molecule by a T cell receptor (TCR) on the surface of T cells. However, TCR-pMHC interactions alone are not sufficient to fully activate T cells. They require the participation of the co-receptors CD4 and CD8.
These transmembrane glycoproteins define distinct T cell subsets. CD4 is expressed on helper T cells (Th1, Th2, Th17) and regulatory T cells (Tregs). CD8 is found on cytotoxic T lymphocytes (CTLs) and CD8 regulatory T cells.
CD4 and CD8 enhance T cell signaling by binding specifically to MHC class II and MHC class I molecules, respectively, on antigen-presenting cells (APCs). This ensures precise and efficient communication within the adaptive immune system.
Antigen Processing and Presentation Pathways
MHC molecules serve as transport systems that link intracellular or extracellular antigen sources to the cell surface, where T cells can recognize them.
MHC Class I
MHC class I acts as a transporter between the cytoplasmic compartment and the cell surface. It primarily presents endogenous antigens. These are proteins that are newly synthesized within the cell, including self-antigens, viral peptides, and tumor-associated antigens.
These proteins are partially degraded in the cytoplasm by the proteasome. They are then transported into the endoplasmic reticulum via TAP (Transporter associated with Antigen Processing). They are loaded onto MHC class I molecules before being displayed on the cell surface.
Thus, CD8+ T cells mainly recognize endogenously derived peptides. This allows them to monitor the intracellular health of the organism and eliminate infected or transformed cells.
MHC Class II
MHC class II, by contrast, functions as a transport system between endosomes and the cell surface. It presents exogenous antigens. These are proteins that originate from outside the cell.
These foreign particles, such as bacterial, fungal, or parasitic proteins, as well as soluble antigens, are internalized via endocytosis. They are degraded into peptides within the endosomal compartment.
The MHC class II molecule then binds these peptides and transports them to the cell surface. There, they are presented to CD4+ T helper cells, which orchestrate immune responses through cytokine release and B cell activation.
Structural Differences Between MHC Class I and II Binding Grooves
MHC Class I: A Closed Groove with Defined Peptide Length
The MHC class I binding groove is closed at both ends. This restricts the length of peptides it can accommodate. Typically, MHC I binds short peptides of 8 to 10 amino acids, most often nonamers.
Peptides bind in an extended conformation. They depend on anchor residues, which are specific amino acids that fit into deep hydrophobic pockets. These anchor residues are most commonly at positions P2 and P9.
These anchor interactions stabilize the peptide-MHC complex. Exposed residues project upward to interact with the T cell receptor (TCR) and determine antigen specificity.
MHC Class II: An Open Groove with Extended Peptide Binding
In contrast, the MHC class II binding groove is open at both ends. This allows peptides of variable lengths, typically 13 to 25 amino acids, to bind. The peptides can extend beyond the groove, resulting in more flexible and diverse antigen presentation to CD4+ T cells.
The bound peptide typically adopts a type II polyproline helix conformation. This fits into specific binding pockets within the MHC class II molecule. Major anchor positions are located at P1, P4, P6, and P9.
At these positions, the side chains of certain amino acids interact with deep, hydrophobic or charged pockets in the MHC molecule. P1 often accommodates an aromatic amino acid (e.g., phenylalanine, tyrosine, or tryptophan). P4 typically binds a hydrophobic or polar/charged amino acid. P6 recognizes an amino acid specific to the individual MHC II allele. P9 prefers a hydrophobic amino acid.
Minor anchor residues at positions such as P2, P3, P7, and P10 can further stabilize the interaction. For researchers studying peptide binding, tools like a peptide solubility predictor can assist in experimental design.
Summary: Matching Peptides to MHC Class I and II
Understanding these differences is critical for designing peptide-based vaccines, T cell assays, and epitope mapping strategies that align with either class I or class II presentation pathways.
- MHC Class I: Peptide source is endogenous (self, viral, tumor). Peptide length is 8 to 10 amino acids. Groove structure is closed at both ends. Anchor positions are P2 and P9. Recognized by CD8+ cytotoxic T cells.
- MHC Class II: Peptide source is exogenous (bacterial, fungal, parasitic, soluble proteins). Peptide length is 13 to 25 amino acids. Groove structure is open at both ends. Anchor positions are P1, P4, P6, and P9 (plus minor anchors). Recognized by CD4+ helper T cells.
For researchers working with peptides, a comprehensive peptide glossary can clarify key terms. Additionally, the peptide interaction checker may help evaluate potential interactions in complex assays.
Conclusion
MHC class I and II molecules serve distinct roles in adaptive immunity, shaped by their structural differences in binding groove architecture. MHC class I presents short endogenous peptides to CD8+ T cells, while MHC class II presents longer exogenous peptides to CD4+ T cells. These fundamental differences guide vaccine design, T cell assay development, and epitope prediction efforts.